| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |